Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS.
Piotti A, Novelli D, Meessen JMTA, Ferlicca D, Coppolecchia S, Marino A, Salati G, Savioli M, Grasselli G, Bellani G, Pesenti A, Masson S, Caironi P, Gattinoni L, Gobbi M, Fracasso C, Latini R; ALBIOS Investigators. Piotti A, et al. Among authors: masson s. Crit Care. 2021 Mar 19;25(1):113. doi: 10.1186/s13054-021-03545-1. Crit Care. 2021. PMID: 33741039 Free PMC article. Clinical Trial.
Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G, Latini R, Gattinoni L. Masson S, et al. Intensive Care Med. 2015 Jan;41(1):12-20. doi: 10.1007/s00134-014-3514-2. Epub 2014 Oct 16. Intensive Care Med. 2015. PMID: 25319385 Clinical Trial.
Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
Masson S, Caironi P, Fanizza C, Carrer S, Caricato A, Fassini P, Vago T, Romero M, Tognoni G, Gattinoni L, Latini R; Albumin Italian Outcome Sepsis Study Investigators. Masson S, et al. Crit Care Med. 2016 Apr;44(4):707-16. doi: 10.1097/CCM.0000000000001473. Crit Care Med. 2016. PMID: 26571184 Clinical Trial.
Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
Caironi P, Masson S, Mauri T, Bottazzi B, Leone R, Magnoli M, Barlera S, Mamprin F, Fedele A, Mantovani A, Tognoni G, Pesenti A, Gattinoni L, Latini R; ALBIOS Biomarkers Study Investigators. Caironi P, et al. Among authors: masson s. Eur J Clin Invest. 2017 Jan;47(1):73-83. doi: 10.1111/eci.12704. Epub 2016 Dec 14. Eur J Clin Invest. 2017. PMID: 27864924 Free PMC article.
Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
Røsjø H, Masson S, Caironi P, Stridsberg M, Magnoli M, Christensen G, Moise G, Urbano MC, Gattinoni L, Pesenti A, Latini R, Omland T; ALBIOS Biomarkers Study Investigators. Røsjø H, et al. Among authors: masson s. Crit Care Med. 2018 May;46(5):e404-e410. doi: 10.1097/CCM.0000000000003050. Crit Care Med. 2018. PMID: 29481425 Clinical Trial.
Albumin replacement in patients with severe sepsis or septic shock.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L; ALBIOS Study Investigators. Caironi P, et al. Among authors: masson s. N Engl J Med. 2014 Apr 10;370(15):1412-21. doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18. N Engl J Med. 2014. PMID: 24635772 Free article. Clinical Trial.
Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G, Latini R, Gattinoni L. Masson S, et al. Intensive Care Med. 2015 Sep;41(9):1736. doi: 10.1007/s00134-015-3982-z. Intensive Care Med. 2015. PMID: 26183490 No abstract available.
Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Maggio G, Cavana M, Tognoni G, Pesenti A, Gattinoni L, Masson S; ALBIOS Study Investigators. Caironi P, et al. Among authors: masson s. Chest. 2017 Aug;152(2):312-320. doi: 10.1016/j.chest.2017.03.035. Epub 2017 Apr 12. Chest. 2017. PMID: 28411114 Free article. Clinical Trial.
470 results